Announcements Trials
Browse Landscape

Phase

Phase 2 1Phase 1 1

Status

Completed 1Active not recruiting 1

Sponsor Class

OTHER 1NETWORK 1

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Myeloid 2Lymphoid 2Other neoplasm 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 27Leukemia 26Lymphoma 16Leukemia, Myeloid, Acute 16Hematologic Neoplasms 12Lymphoma, Non-Hodgkin 11Myelodysplastic Syndromes 10Leukemia, Myelogenous, Chronic, BCR-ABL Positive 9Leukemia, Lymphocytic, Chronic, B-Cell 9Hodgkin Disease 8Neoplasms 5Myeloproliferative Disorders 4Leukemia, Biphenotypic, Acute 4Leukemia, B-Cell 4Hematologic Diseases 4Burkitt Lymphoma 4Recurrence 3Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 3Multiple Myeloma 3Lymphoma, Follicular 3Leukemia, Lymphoid 3Graft vs Host Disease 3Waldenstrom Macroglobulinemia 2Primary Myelofibrosis 2Preleukemia 2Precancerous Conditions 2Neoplasms by Histologic Type 2Lymphoproliferative Disorders 2Lymphoma, Mantle-Cell 2Lymphoma, Large B-Cell, Diffuse 2

Interventions

Cyclophosphamide 59fludarabine phosphate 53Peripheral Blood Stem Cell Transplantation 43Tacrolimus 40Mycophenolic Acid 36Busulfan 33Whole-Body Irradiation 32Antilymphocyte Serum 28Cyclosporine 27Methotrexate 25fludarabine 19Filgrastim 18Melphalan 17Radiotherapy 15Methylprednisolone 13Etoposide 12Cord Blood Stem Cell Transplantation 12thymoglobulin 11Sirolimus 11ruxolitinib 10Flow Cytometry 10Psychiatric Rehabilitation 9Azacitidine 9Stem Cell Transplantation 7Granulocyte Colony-Stimulating Factor 7Decitabine 7Therapeutics 6Imatinib Mesylate 6Cytarabine 6Cyclosporins 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Primary Myelofibrosis × Mesna × Other hematologic neoplasm × Clear all
NCT06001385 2026-02-05

OPTIMIZE

Center for International Blood and Marrow Transplant Research

Phase 2 Active not recruiting
313 enrolled
LymphoidMyeloidOther hematologic neoplasmOther neoplasm

Bone Marrow Diseases, Hematologic Diseases, Immune System Diseases, Immunoproliferative Disorders, Leukemia, Leukemia, Lymphoid, Leukemia, Myeloid, Lymphatic Diseases, Lymphoma, Lymphoproliferative Disorders, Myelodysplastic Syndromes, Myeloproliferative Disorders, Neoplasms, Neoplasms by Histologic Type, Precancerous Conditions, Preleukemia, Leukemia, B-Cell, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Biphenotypic, Acute, Leukemia, Prolymphocytic, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Primary Myelofibrosis

NCT02167958 2019-10-15

Nonmyeloablative Hematopoietic Cell Transplantation (HCT) for Patients With Hematologic Malignancies Using Related, HLA-Haploidentical Donors: A Pilot Trial of Peripheral Blood Stem Cells (PBSC) as the Donor Source

University of Pittsburgh

Phase 1 Completed
28 enrolled
LymphoidMyeloidOther hematologic neoplasm

Leukemia, Lymphoma, Primary Myelofibrosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡